Telehealth Stock Could Rebound Off Long-Term Trendline

By Fernanda Horner | October 23, 2025, 12:14 PM

Telehealth stock Hims & Hers Health Inc (NYSE:HIMS) just suffered a steep pullback after President Donald Trump's said Novo Nordisk's (NVO) weight-loss and diabetes drugs, Wegovy and Ozempic, should be reduced to $150 a month. The security is still up 98.9% year-to-date, however, with a floor of support lingering below at the $40 level.

At last check, HIMS was up 0.8% to trade at $47.82. It looks like the stock could continue higher, too, as those recent losses placed the shares near a long-term trendline that has historically bullish implications.

According to Schaeffer's Senior Quantitative Analyst Rocky White, Hims & Hers Health stock is within 0.75 of the 200-day moving average's 20-day average true range (ATR), after spending at least 80% of the last 10 days and 80% of the last two months above it.

This signal has occurred six other times in the past 10 years, after which the equity was higher one week later 78% of the time to average a 6.3% pop. From its current perch, a similar move would place HIMS back above $51.

It's also worth noting that HIMS has a history of exceeding options traders' volatility expectations. This is per its Schaeffer's Volatility Scorecard (SVS) of 83 out of 100.

Mentioned In This Article

HIMS

+2.17%

Hims & Hers Health Inc

Latest News

4 hours	Telehealth Stock Could Rebound Off Long-Term Trendline HIMS Schaeffer's Research
15 hours	1 Mid-Cap Stock Worth Your Attention and 2 We Avoid HIMS StockStory
Oct-22	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory HIMS Insider Monkey
Oct-22	Why Hims & Hers Health, Inc. (HIMS) Dipped More Than Broader Market Today HIMS Zacks
Oct-22	Wall Street Wonders if Grail's Cancer Test Results Are a True Positive HIMS Barrons.com
Oct-22	Hims & Hers Advances AI-Powered Personalized Digital Healthcare HIMS Zacks
Oct-21	KeyBanc starts Hims & Hers with caution on margin HIMS Investing.com
Oct-21	CEO Andrew Dudum Is Ditching Hims & Hers Stock. Should You? HIMS Barchart
Oct-21	HIMS Stock Declines Despite Launch of New Specialty in Women's Health HIMS Zacks
Oct-21	Goldman downgraded, Coinbase initiated: Wall Street's top analyst calls HIMS The Fly
Oct-20	Hims & Hers Health (HIMS) Stock Is Up, What You Need To Know HIMS StockStory
Oct-20	HQY Expands Access With GLP-1 Telehealth & Direct HSA Platforms HIMS Zacks
Oct-20	Hims & Hers Health, Inc. (HIMS) is Attracting Investor Attention: Here is What You Should Know HIMS Zacks
Oct-17	Hims & Hers CEO sells, analyst calls on Planet Fitness & Deere HIMS Yahoo Finance Video
Oct-17	Hims & Hers Stock Nosedives -- CEO Cashes Out $11 Million Stake HIMS GuruFocus.com

Telehealth Stock Could Rebound Off Long-Term Trendline

Mentioned In This Article

Latest News

Upgrade your FINVIZ experience